After completing this activity, pharmacists should be able to:
- Describe the extent and consequences of over-reliance on short-acting bronchodilators in asthma
- Compare outcomes with anti-inflammatory relievers for patients with mild asthma
- Discuss with patients the benefits of anti-inflammatory reliever therapy for mild asthma
Competency Standards addressed (2016): 2.2, 3.2, 3.5.
Accreditation number: A2008RP2 Accreditation expires: 31/07/2022
This activity has been accredited for 1 hour of Group One CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.